In U.S., biosimilars still await FDA decision.
Finkelstein
Joel B
JB
D017277:Drug Approval / Q000331:legislation & jurisprudence; D004345:Drug Industry; D016568:Drugs, Generic / Q000493:pharmacokinetics; D006801:Humans; D007880:Legislation, Drug; D013810:Therapeutic Equivalency; D014481:United States; D014486:United States Food and Drug Administration
D016568:Drugs, Generic